Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROACTEMRA vs ROMIDEPSIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROACTEMRA vs ROMIDEPSIN: Safety Overview

Metric ROACTEMRA ROMIDEPSIN
Total FAERS Reports 164 1,282
Deaths Reported 14 343
Death Rate 8.5% 26.8%
Hospitalizations 65 458
Average Patient Age 51.2 yrs 64.7 yrs
% Female Patients N/A 46.5%
FDA Approval Date N/A Mar 13, 2020
Manufacturer N/A Fresenius Kabi USA, LLC
Marketing Status N/A Prescription